Search details
1.
Overview of premedication prescription and intake in an oncology day hospital: What do we need to change to improve patient management?
J Oncol Pharm Pract
; 30(1): 88-99, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37038369
2.
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Gynecol Oncol
; 169: 78-84, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36521352
3.
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.
Clin Res Hepatol Gastroenterol
; 46(5): 101888, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35189426
4.
KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine.
Expert Opin Biol Ther
; 21(10): 1325-1334, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34378483
5.
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy.
Expert Rev Anticancer Ther
; 20(5): 365-372, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32302244
6.
Pembrolizumab for the treatment of colorectal cancer.
Expert Opin Biol Ther
; 20(3): 219-226, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31952453
7.
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Clin Lung Cancer
; 21(5): e497-e510, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32605892
Results
1 -
7
de 7
1
Next >
>>